Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
1 other identifier
interventional
54
1 country
1
Brief Summary
The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets. In this study, participants' hospital rooms will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2022
CompletedFirst Posted
Study publicly available on registry
August 29, 2022
CompletedStudy Start
First participant enrolled
September 13, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
July 29, 2026
February 1, 2026
4.9 years
August 26, 2022
July 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean absolute error of urine volume (in mL) as measured by device compared to standard of care nurse assessment
Up to 14 days
Secondary Outcomes (10)
Correlation between daily patient fluid balance (difference between fluid input and output in mL) as measured by device measurements or standard of care nurse assessment and the change in daily weight
Up to 14 days
Mean absolute error of urine volume (in mL) as measured by device
Up to 14 days
Time (in mins) spent handling/recording patient waste
First 3 days of patient's HCT conditioning
Levels of chemotherapy drugs detectable on room surfaces as measured by surface testing
First 3 days of patient's HCT conditioning
Time (in mins) between nurse logging of patient urination in electronic medical records and device-based logging of patient urination
Up to 14 days
- +5 more secondary outcomes
Study Arms (2)
Device
EXPERIMENTALPatients use toilet device to measure fluid output and self-report event types
Control
NO INTERVENTIONCollection in standard hats + nurses visually assessing fluid volumes
Interventions
Device will be installed on toilet of patients will in hospital to measure all waste output.
Eligibility Criteria
You may qualify if:
- Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic OR currently undergoing treatment for HF in the Duke Cardiology Clinic with order of strict I/O monitoring
- Age 18-80 years
- Karnofsky Performance Scale (KPS) ≥ 70 if a BMT patient
- Able to read/write English
You may not qualify if:
- Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter.
- Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning OR during HF treatment.
- Women who are pregnant
- Patient height \< 5'3" if they are a patient within the Duke Cardiology Clinic
- Disabled individuals using wheelchairs or transfer devices to use bathroom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University
Durham, North Carolina, 27705, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chenyu Lin, MD
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2022
First Posted
August 29, 2022
Study Start
September 13, 2023
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
July 29, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share